The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment

Paolo Bigliano; Andrea CALCAGNO; Anna Lucchini; Sabrina Audagnotto; Chiara Montrucchio; Letizia Marinaro; Chiara Alcantarini; Valeria Ghisetti; Giovanni Di Perri; Stefano Bonora

doi:10.3851/IMP3221

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment

Paolo Bigliano
, Andrea CALCAGNO
, Anna Lucchini
, Sabrina Audagnotto
, Chiara Montrucchio
, Letizia Marinaro
, Chiara Alcantarini
, Valeria Ghisetti
, Giovanni Di Perri
, Stefano Bonora

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

HIV late presenters are at high risk of Cytomegalovirus reactivation and end-organ disease. CMV viremia has been associated with poor survival but the effect of anti-CMV treatment has not been studied in this setting.

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	Antiviral Therapy
DOIs	https://doi.org/10.3851/IMP3221
Publication status	Published - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3851/IMP3221

https://hdl.handle.net/11579/216833

Cite this

@article{50d955b2cd0949a5bceca65359962e3b,

title = "The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment",

abstract = "HIV late presenters are at high risk of Cytomegalovirus reactivation and end-organ disease. CMV viremia has been associated with poor survival but the effect of anti-CMV treatment has not been studied in this setting.",

author = "Paolo Bigliano and Andrea CALCAGNO and Anna Lucchini and Sabrina Audagnotto and Chiara Montrucchio and Letizia Marinaro and Chiara Alcantarini and Valeria Ghisetti and \{Di Perri\}, Giovanni and Stefano Bonora",

year = "2018",

doi = "10.3851/IMP3221",

language = "English",

pages = "1--6",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "Sage Publications",

}

TY - JOUR

T1 - The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment

AU - Bigliano, Paolo

AU - CALCAGNO, Andrea

AU - Lucchini, Anna

AU - Audagnotto, Sabrina

AU - Montrucchio, Chiara

AU - Marinaro, Letizia

AU - Alcantarini, Chiara

AU - Ghisetti, Valeria

AU - Di Perri, Giovanni

AU - Bonora, Stefano

PY - 2018

Y1 - 2018

N2 - HIV late presenters are at high risk of Cytomegalovirus reactivation and end-organ disease. CMV viremia has been associated with poor survival but the effect of anti-CMV treatment has not been studied in this setting.

AB - HIV late presenters are at high risk of Cytomegalovirus reactivation and end-organ disease. CMV viremia has been associated with poor survival but the effect of anti-CMV treatment has not been studied in this setting.

UR - https://iris.uniupo.it/handle/11579/216833

U2 - 10.3851/IMP3221

DO - 10.3851/IMP3221

M3 - Article

SN - 1359-6535

SP - 1

EP - 6

JO - Antiviral Therapy

JF - Antiviral Therapy

ER -

The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this